Actions
Kimberly Boynton Joins NBT Bancorp Board as Healthcare and Real Estate Expert
NBT Bancorp Inc. announced Kimberly A. Boynton’s appointment to its board of directors, bringing over two decades of executive experience in healthcare, finance, and commercial real estate.
Industrial Logistics Properties Trust Names Anthony Paula as New CFO
RMR Group executive replaces Tiffany Sy at industrial logistics REIT; transition takes effect Oct. 1 amid portfolio expansion across 39 states.
Taltson Critical Minerals appoints CFO, raises $85,000 in private placement
The Vancouver‑based explorer named Casey Forward as chief financial officer and closed a $85,000 non‑brokered private placement of 2.125 million units, with an insider buying 23.5% of the issue.
PACS Group Appoints Patrick Murphy as New Chief Legal Officer
Patrick Murphy takes over as Chief Legal Officer and Corporate Secretary, succeeding John Mitchell who retired after 15 years at the company.
Roche receives EU approval for Susvimo, eyeing new market opportunities
Pharmaceutical giant Roche has obtained EU approval for its eye medication Susvimo, opening up new sales channels and bringing the stock back into focus.
Vireo Growth acquires Nevada dispensary for $500K in cash and shares
Minneapolis-based Vireo Growth completed a $500,000 acquisition of M3 Wellness in Nevada, paying $290,000 in cash and issuing subordinate voting shares at a $15.12 valuation.
Nyxoah appoints interim CFO, reaffirms 2026 revenue and margin guidance
Nyxoah SA said President International Loïc Moreau will serve as interim chief financial officer after John Landry's departure on Oct. 2, and confirmed its 2026 revenue, margin and expense targets.
Vicor Raises Q3 Revenue Guidance on Licensing Royalties
Andover-based Vicor Corporation boosted its third-quarter revenue outlook by more than a decade, citing royalties from a recent licensing deal on its Vertical Power Delivery technology.
Qnity Electronics Added to PHLX Semiconductor Sector Index
The Wilmington-based chip maker joins the benchmark index tracking the 30 largest eligible U.S. semiconductor companies, following its NYSE listing.
Toro adds Tennant CEO David Huml to board of directors
The Toro Company appointed David Huml, chief executive of Tennant, to its board effective immediately, citing his expertise in robotics and smart‑connected technologies.
Travere Therapeutics Names CEO Bradley Campbell to Succeed Eric Dube
Eric Dube steps down as CEO on December 1, with Campbell taking over after a board-led search for a successor focused on rare kidney disease therapies.
CVRx Names John Landry as New CFO, Succeeding Oasheim
John Landry, former CFO of Nyxoah SA, will take over as chief financial officer of CVRx starting October 12, 2026, following Jared Oasheim’s transition.
Novartis Q1 Revenue Falls 1% as Generics Erode Drug Market Share
Pharmaceutical giant Novartis reported a first-quarter revenue decline of 1% and a 12% drop in core operating profit, driven by patent expirations and intensified generic competition.
Nestlé, Novartis, Roche et UBS : quelles sont les principales locomotives du marché boursier suisse ?
La Suisse peut-être un pays relativement petit, mais sa bourse regroupe des entreprises aux influences globales immenses.
Scinai Regains Nasdaq Compliance After 19-Day Bid Price Hold
Scinai Immunotherapeutics Ltd. returned to full compliance with Nasdaq’s minimum bid price rule after a 19-day period of adherence, following a prior violation in March.
FDA grants platform technology designation to Precigen's AdenoVerse
The U.S. FDA has awarded platform technology status to Precigen's AdenoVerse immunotherapy platform, which underpins the approved PAPZIMEOS treatment and several HPV‑related cancer studies.
Latam Lithium to hold shareholder vote on 3-for-1 consolidation
Latam Lithium Corp. has scheduled an annual general and special meeting for October 22, 2026, to vote on a three-for-one share consolidation, which will reduce the number of outstanding shares from approximately 35.3 million to 11.8 million.
SEC’s Tokenized Stock Rules Face TD Cowen’s Skepticism on Adoption
The SEC’s new framework for tokenized stock trading may not spur near-term demand, as investors already have efficient access to traditional markets, analysts warn.
Moderna Stock Hits 52‑Week High at $176.75
The biotech firm’s shares rose to their yearly peak amid strong vaccine‑related developments, a $2 billion convertible notes offering and mixed analyst ratings, while its market cap stands near $70.4 billion.
US Stocks Rise on Oil Price Decline, Nasdaq 100 Hits 3-Month High
US stock markets saw significant gains on Monday, supported by hopes for diplomatic progress in the Middle East and falling oil prices. The Nasdaq 100 reached its highest level in three months.
Ethan Allen faces proxy battle over CEO succession process
Activist shareholder Doug Bergeron challenges board’s succession plan, seeking independent CEO search and director nominees
Post Holdings Shares Hit 52-Week Low as Analysts Cut Forecasts
Cereal maker's stock fell to $75.38, down 36% from its 52-week high, after five analysts revised earnings estimates lower despite a solid third quarter.
Seven Steps to Successful Investment: A Guide for Beginners
A seven-step guide to investing and building wealth, suitable for beginners and experienced investors alike. Learn how to define goals, assess risk tolerance, and choose the right investment instruments.
Kromek’s Shares Drop Amid Revenue Shift as Non-Licensed Business Expands
Kromek Group plc’s shares fell on Tuesday as the AIM-listed company reported a revenue mix shift toward non-licensed business, with growth in photon-counting CT and SPECT imaging driving a 112% forecast rise in non-licensed revenue by FY 2027.